Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
Change to the spokesperson and acting spokesperson of the company.
2022-05-06
The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting.(additional matters for discussion)
2022-05-06
The Company is invited to attend an institutional investor conference hosted by President Securities on April 28, 2022.
2022-04-27
The Board of Directors approved dividend distribution
2022-03-11
The Board of Directors approved 2021 consolidated financial statements.
2022-03-11
The Board of Directors release the prohibition on managers from participation in competition businesses.
2022-03-11
The Board of Directors approved issue new shares for capital increase by earnings recapitalization.
2022-03-11
The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting.
2022-03-11
Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding Board Meeting Resolution on dividend distribution.
2022-03-01
Announcement according to the Article 25.1.4 of Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies.
2021-12-24